In CRC cells the anti-tumorigenic effects of 1,25D3 are influenced by the amount of CaSR expressed in a cell and by the activity of this receptor (Singh et al., 2013; Aggarwal et al., 2016). The gene discussed is CASR; the disease is colorectal carcinoma.